These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 1827941)

  • 1. Myocardial perfusion imaging with technetium-99m-labeled agents.
    Maddahi J; Kiat H; Berman DS
    Am J Cardiol; 1991 May; 67(14):27D-34D. PubMed ID: 1827941
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The new 99mTc myocardial perfusion imaging agents: 99mTc-sestamibi and 99mTc-teboroxime.
    Berman DS; Kiat H; Maddahi J
    Circulation; 1991 Sep; 84(3 Suppl):I7-21. PubMed ID: 1832100
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Technetium-labeled myocardial perfusion agents.
    Heo J; Iskandrian AS
    Cardiol Clin; 1994 May; 12(2):187-98. PubMed ID: 8033172
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of SPECT using technetium-99m agents and thallium-201 and PET for the assessment of myocardial perfusion and viability.
    Berman DS; Kiat H; Van Train KF; Friedman J; Garcia EV; Maddahi J
    Am J Cardiol; 1990 Oct; 66(13):72E-79E. PubMed ID: 2145750
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Teboroxime, sestamibi and thallium-201 as markers of myocardial hypoperfusion: comparison by quantitative dual-isotope autoradiography in rabbits.
    Weinstein H; Reinhardt CP; Leppo JA
    J Nucl Med; 1993 Sep; 34(9):1510-7. PubMed ID: 8355072
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Experimental studies of the physiologic properties of technetium-99m agents: myocardial transport of perfusion imaging agents.
    Meerdink DJ; Leppo JA
    Am J Cardiol; 1990 Oct; 66(13):9E-15E. PubMed ID: 2145753
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Physiological basis of myocardial perfusion imaging with the technetium 99m agents.
    Beller GA; Watson DD
    Semin Nucl Med; 1991 Jul; 21(3):173-81. PubMed ID: 1835136
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical experience with technetium-99m teboroxime, a neutral, lipophilic myocardial perfusion imaging agent.
    Johnson LL; Seldin DW
    Am J Cardiol; 1990 Oct; 66(13):63E-67E. PubMed ID: 2220625
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Technetium-99m-labelled HL91 and technetium-99m-labelled MIBI SPECT imaging for the detection of ischaemic viable myocardium: a preliminary study.
    Liu M; Ma Z; Guo X; Zhu J; Su J
    Clin Physiol Funct Imaging; 2012 Jan; 32(1):25-32. PubMed ID: 22152075
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A review of cardiac imaging with sestamibi and teboroxime.
    Leppo JA; DePuey EG; Johnson LL
    J Nucl Med; 1991 Oct; 32(10):2012-22. PubMed ID: 1833519
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of technetium-99m teboroxime tomography with automated quantitative coronary arteriography and thallium-201 tomographic imaging.
    Fleming RM; Kirkeeide RL; Taegtmeyer H; Adyanthaya A; Cassidy DB; Goldstein RA
    J Am Coll Cardiol; 1991 May; 17(6):1297-302. PubMed ID: 2016447
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Are technetium-99m-labeled myocardial perfusion agents adequate for detection of myocardial viability?
    Caner B; Beller GA
    Clin Cardiol; 1998 Apr; 21(4):235-42. PubMed ID: 9562932
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Myocardial perfusion imaging with technetium-99m sestamibi SPECT in the evaluation of coronary artery disease.
    Maddahi J; Kiat H; Van Train KF; Prigent F; Friedman J; Garcia EV; Alazraki N; DePuey EG; Nichols K; Berman DS
    Am J Cardiol; 1990 Oct; 66(13):55E-62E. PubMed ID: 2145748
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Canadian exercise technetium 99m-labeled teboroxime single-photon emission computed tomographic study. Canadian Exercise Teboroxime SPECT Study Investigators.
    Burns RJ; Iles S; Fung AY; Wright LM; Daigneault L
    J Nucl Cardiol; 1995; 2(2 Pt 1):117-25. PubMed ID: 9420776
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Myocardial perfusion imaging using single-photon emission computed tomography.
    Garvin AA; Cullom SJ; Garcia EV
    Am J Card Imaging; 1994 Apr; 8(2):189-98. PubMed ID: 8032191
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Compartmental modeling of technetium-99m-labeled teboroxime with dynamic single-photon emission computed tomography: comparison with static thallium-201 in a canine model.
    Di Bella EV; Ross SG; Kadrmas DJ; Khare HS; Christian PE; McJames S; Gullberg AG
    Invest Radiol; 2001 Mar; 36(3):178-85. PubMed ID: 11228582
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Technetium 99m sestamibi in the assessment of chronic coronary artery disease.
    Berman DS; Kiat H; Van Train K; Garcia E; Friedman J; Maddahi J
    Semin Nucl Med; 1991 Jul; 21(3):190-212. PubMed ID: 1835137
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison between thallium-201, technetium-99m-sestamibi and technetium-99m-teboroxime planar myocardial perfusion imaging in detection of coronary artery disease.
    Taillefer R; Lambert R; Essiambre R; Phaneuf DC; Léveillé J
    J Nucl Med; 1992 Jun; 33(6):1091-8. PubMed ID: 1534575
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative feasibility of separate or simultaneous rest thallium-201/stress technetium-99m-sestamibi dual-isotope myocardial perfusion SPECT.
    Kiat H; Germano G; Friedman J; Van Train K; Silagan G; Wang FP; Maddahi J; Berman D
    J Nucl Med; 1994 Apr; 35(4):542-8. PubMed ID: 8151372
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Technetium-99m-tetrofosmin in dipyridamole-stress myocardial SPECT imaging: intraindividual comparison with technetium-99m-sestamibi.
    Flamen P; Bossuyt A; Franken PR
    J Nucl Med; 1995 Nov; 36(11):2009-15. PubMed ID: 7472590
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.